Physician profile
John D Bruns
NPI 1083642805
$2,421.01
in general payments reported to CMS, 2019-2025
19 companies · $275 in 2025
The $275 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $407 · 2021: $390 · 2022: $245 · 2023: $409 · 2024: $312 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $793.82 | 2019-2024 | Jornay Pm |
| Corium, LLC | $286.78 | 2021-2025 | Azstarys |
| Cranial Technologies, INC | $195.12 | 2019-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $160.19 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Takeda Pharmaceuticals U.S.A., INC. | $155.89 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $120.24 | 2019-2025 | Relexxii |
| Sanofi-Aventis U.S. LLC | $109.53 | 2024-2025 | |
| Glaxosmithkline, LLC. | $94.77 | 2019-2021 | |
| Neos Therapeutics, LP | $90.55 | 2019-2023 | Cotempla Xr-Odt |
| Supernus Pharmaceuticals, INC. | $66.98 | 2021-2023 | Qelbree |
| Shire North American Group INC | $55.32 | 2019 | |
| Collegium Pharmaceutical, INC. | $52.75 | 2025 | Jornay Pm |
| Kaleo, INC. | $51.62 | 2019-2023 | Auvi-Q |
| Pfizer INC. | $43.02 | 2020-2023 | |
| Sobi, INC | $40.80 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $39.92 | 2020-2025 | Dyanavel Xr |
| Adlon Therapeutics L.P. | $25.88 | 2021 | |
| Sanofi Pasteur INC. | $23.47 | 2019-2021 | |
| Dermira, INC. | $14.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bruns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.